Analysis of Real-world Treatment Patterns in Patients with Prurigo Nodularis
Overview
Affiliations
Murota H, Matsumoto M, Arima K, Yoshida T, Fujita H J Dermatol. 2024; 52(2):348-352.
PMID: 39225549 PMC: 11807362. DOI: 10.1111/1346-8138.17400.
Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics.
Yook H, Lee J Int J Mol Sci. 2024; 25(10).
PMID: 38791201 PMC: 11121340. DOI: 10.3390/ijms25105164.
Prurigo nodularis: new insights into pathogenesis and novel therapeutics.
Liao V, Cornman H, Ma E, Kwatra S Br J Dermatol. 2024; 190(6):798-810.
PMID: 38345154 PMC: 11099982. DOI: 10.1093/bjd/ljae052.
Morgan C, Thomas M, Heywood B, Stander S, Kwatra S, Jabbar-Lopez Z JID Innov. 2023; 3(6):100233.
PMID: 38024558 PMC: 10661494. DOI: 10.1016/j.xjidi.2023.100233.
A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis.
Zhang Z, Li S, Wang Y, Zhao J An Bras Dermatol. 2023; 98(4):440-448.
PMID: 36966024 PMC: 10334323. DOI: 10.1016/j.abd.2022.09.008.